Japan Animal Referral Medical Center Co., Ltd. (6039.T) owns and operates veterinary hospitals providing advanced secondary medical care for companion animals, primarily dogs and cats, in Japan. The company offers specialized services including diagnostic imaging with CT, MRI, and PET-CT equipment; radiation therapy; surgical interventions for severe conditions; and comprehensive testing and treatment beyond primary care capabilities available at local animal clinics. Its operations emphasize a division-of-labor model with family animal hospitals, serving pet owners across Japan from its headquarters in Kawasaki City, Kanagawa Prefecture, where it was founded in 2005. In recent developments, the company completed an equity buyback program in March 2024, repurchasing 71,300 shares for approximately 139.75 million yen, and announced changes in shareholder stakes, including a reduction in Pilgrim Partners Asia's ownership in associated entity Advanced Animal Healthcare to 11.75% as of early 2025.